Hospital Mortality and Resource Implications of Hospitalisation with COVID-19 in London, UK: A Prospective Cohort Study
Savvas Vlachos(King's College Hospital), Ritesh Maharaj(King's College Hospital), William Bernal(King's College - North Carolina), Christopher Stovin(King's College Hospital NHS Foundation Trust), Victoria Metaxa(Apple (Israel)), Adrian Wong(Hadassah Medical Center), Kai Lee(King's College Hospital NHS Foundation Trust), R. Banerjee(King's College Hospital NHS Foundation Trust), Sara Al-Hashimi(King's College Hospital NHS Foundation Trust), Katrina Abernethy, Jimstan Periselneris(King's College Hospital NHS Foundation Trust), Carmen Lopez Soto(King's College Hospital NHS Foundation Trust), Fatimah Juma(King's College Hospital NHS Foundation Trust), Sergio Canestrini(St. Michael's Hospital), Tanya Patrick(University College London), Budoor Albudoor(King's College Hospital NHS Foundation Trust)
Cited by 16
Related Papers
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
|The Lancet|2021|523
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
|The Lancet|2022|384
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Diagnosis of severe respiratory infections in immunocompromised patients
|Intensive Care Medicine|2020|340